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ABSTRACT. The systemic inflammatory response syndrome (SIRS) is a common cause of mortality in dogs. This 
study aims to investigate the diagnostic value of markers C-reactive protein (CRP), soluble urokinase-type plasmin-
ogen activator receptor (suPAR) and neopterin in dogs with SIRS. The materials of the study consist of 30 dogs with 
SIRS and 15 healthy dogs that show no clinical symptom, 45 dogs in total. CRP, suPAR and neopterin levels of the 
serum samples were determined by ELISA using commercial kits. In the study, it was found that CRP, suPAR and ne-
opterin levels of dogs with SIRS were significantly higher (P < 0.001, P < 0.01 and P < 0.01, respectively) than those 
in the healthy group. The cut-off values for the healthy dogs and dogs with SIRS for CRP, suPAR and neopterin were 
determined to be 11.20 mg/L, 223.68 ng/L and 3.23 nmol/mL, respectively. At these cut-off values, sensitivity levels 
were determined as high (92.90%) for CRP, moderate (63.30%) for neopterin, and low (53.30%) for suPAR, and high 
specificities (93.30%) were determined for all.
In conclusion, it was determined that CRP showed the best performance for the detection of systemic inflammatory 
response in dogs and neopterin and suPAR could be used as an alternative to CRP. It was also argued that further studies 
were necessary in order to determine diagnosis and prognosis of diseases.
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INTRODUCTION
Systemic inflammatory response syndrome (SIRS) is an immune response against infectious or 
non-infectious factors (Spapen et al., 2006). Two or 
more criteria in the findings of body temperature > 
39.4 oC or < 37.8 oC, heart rate > 140 beat/minute, res-
piration rate > 20/minute, leukocyte > 16.0 x 109/L or 
< 6.0 x 109/L and > 3% band formation are to be found 
in order to diagnose SIRS (Torrente et al., 2015). Sep-
sis is defined as the SIRS developed against infections 
and is indicated as the most notable cause of death in 
infectious diseases (Alberti et al., 2003; Martin et al., 
2003). Although clinical and diagnostic tests are used 
in human and veterinary medicine, more sensitive 
tests are required (Spapen et al., 2006; Nakamura et 
al., 2008; Mylonakis et al., 2011; Ok et al., 2015; Tor-
rente et al., 2015). Especially in veterinary medicine, 
the biomarkers that show diagnostic and prognostic 
values of SIRS or sepsis are not sufficient.
Recent studies state that acute phase proteins can 
provide diagnostically and prognostically signifi-
cant information in monitoring SIRS in infectious 
or non-infectious patients. Acute phase proteins are 
liver-based glycoproteins formed as a result of acute 
phase response. Acute phase proteins are called as 
positive or negative depending on increase (such as 
C-reactive protein and serum amyloid A) or decrease 
(such as albumin and transferrin) in their levels during 
inflammatory states. Acute phase response is a natural 
defense mechanism that plays a part in limiting the 
tissue damage and in stimulating recovery after trau-
ma, infection or inflammation (Eckersall and Conner 
1988; Tothova et al., 2014). Different researchers 
reported that C-reactive protein (CRP), which gives 
non-specific immune responses during the monitoring 
of infectious diseases, could be used in the diagnosis 
of infectious diseases. CRP is a liver-based glycopro-
tein formed as a result of acute phase response. In the 
studies on veterinary medicine, it was stated that se-
rum CRP, one of type-specific acute phase proteins, 
may yield significant information in evaluating the 
clinical presentation of diseases in dogs (Christensen 
et al., 2014; Ok et al., 2015).
The soluble urokinase-type plasminogen activator 
receptor (suPAR) is a potential biomarker reported 
for inflammatory diseases. suPAR is released from 
neutrophils, endothelial and peripheral mononuclear 
blood cells and take part in various immune functions 
such as cell adhesion, migration, differentiation and 
proliferation. Increased suPAR levels are known as 
the determinant of the activation of immune and in-
flammatory systems, and have prognostic values in 
various diseases (Kofoed et al., 2008; Eugen-Olsen, 
2011). Although it was reported that suPAR might 
have had diagnostic values in sepsis, lung and malig-
nant diseases (Stephens et al., 1997; Wittenhagen et 
al., 2004; Eugen-Olsen 2011) no study related to dogs 
with SIRS in veterinary medicine was found in the 
literature surveys.
Neopterin [2-amino-4-hydroxy-6-(D-erythro-1´, 
2´, 3´-trihydroxypropyl)-pteridine] is a low molecular 
weight molecule belonging to the class of pteridines 
which biosynthetically derives from guanosinetriphos-
phate (Murr et al., 2002). Neopterin is synthesized by 
monocytes and macrophages as a result of stimulat-
ing interferon-gamma (IFN- γ) released from active T 
lymphocytes. Neopterin is the sensitive determinant of 
cell-mediated immunity (Murr et al., 2002; Cesur et 
al., 2014). Neopterin release commences 3 days be-
fore T cell proliferation reaches the maximum level. 
Neopterin production increases 1 week before specific 
antibodies emerge. For this reason, neopterin is shown 
as an indicator of early inflammation (Millner et al., 
1998; Berdowska and Zwirska‐Korczala 2001). It was 
determined in the studies on human medicine that 
neopterin levels rise in viral infections, autoimmune 
diseases, inflammatory and malignant diseases (Ber-
dowska and Zwirska‐Korczala 2001). It is known that 
neopterin can be used as an indicator in determining 
the cellular immune response that plays a part in the 
pathogenesis of various diseases (Murr et al., 2002; 
Cesur et al., 2014) however, there are very few studies 
on this matter in the field of veterinary medicine.
It is important to determine reliable test methods 
that provide information in evaluating diagnosis and 
prognosis of patients with SIRS. The purpose of this 
study is to determine CRP, suPAR and neopterin lev-
els of dogs with SIRS.
MATERIALS AND METHODS 
Study design and animals
The animal material of the study consisted of 30 
(18 females, 12 males) dogs, which were of different 
species and gender diagnosed with SIRS by clinical 
symptoms and haematological findings upon having 
been brought to the Internal Diseases Clinic of the 
Faculty of Veterinary Medicine of Sivas Cumhuriyet 
University for examination and treatment, and 15 (8 
females, 7 males) healthy dogs, which showed no dis-
ease symptom.
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The appetite, body temperature, heart rate, respi-
ration rate, respiration type, capillary refill time, de-
hydration degree, changes in mucous membrane co-
lour and mental status of dogs were examined. By the 
evaluation of clinical and haematological findings, 
the dogs diagnosed with SIRS were considered as the 
patient group of the study. 
The study included dogs with at least two of the 
criteria below for SIRS diagnosis (Torrente et al., 
2015).
Body temperature > 39.4 oC or < 37.8 oC
Heart rate > 140 beat/minute
Respiration rate > 20/minute
Leucocyte > 16.0 x 109/L or < 6.0 x 109/L and > 
3% band formation. 
10 ml blood samples in total from each dogs were 
taken from Vena cephalica antebrachii into tubes with 
anticoagulant (potassium EDTA) and no anticoagu-
lant. Haematological parameters (reference value of 
leucocyte was taken as 6.0-16.0 x 109/L) were deter-
mined by the automated haematology analyser (BC-
2800 Vet haematology analyser Mindray Bio-Medi-
cal Electronics Co., Ltd. Nanshan, Shenzhen). Serum 
samples were obtained by centrifuging for 10 min-
utes at 3000 rpm the no anticoagulant blood sample 
in sterile plastic tubes. These samples were stored at 
-80°C until the biochemical analysis. CRP (Tri-Del-
ta Phase Canine CRP, Tri-Delta Diagnostic, Boonton 
Township, NJ), suPAR (Canine suPAR ELISA Kit, 
Yehua Biological Technology Co. Ltd, Shanghai) and 
neopterin (Canine Neopterin ELISA Kit, Yehua Bio-
logical Technology Co. Ltd, Shanghai) levels of the 
serum samples were determined in the ELISA reader 
(Thermo Multiskan GO Microplate Spectrophotom-
eter, Waltham, Massachusetts) by using commercial 
kits by the sandwich enzyme immunoassay method. 
The intra and inter assay coefficient of variation of 
CRP was reported by the manufacturer as 6.5-6.9% 
and 7.8-8.2%, respectively. The assay manufacturer 
reported that the assay range of suPAR was 5-2000 
ng/L, sensitivity 2.43 ng/L, and intra and inter assay 
precision coefficient of variation <8% and <10%, re-
spectively. The measurement limit of the neopterin 
assay is 0.2-60 nmol/ml, sensitivity 0.11 nmol/mL, 
intra and inter assay coefficient of variation <10% and 
<12%, respectively. The study protocol was approved 
by the Ethics Committee of Sivas Cumhuriyet Uni-
versity, Turkey (Approval No: 2016/36).
Statistical Analysis
The data were analyzed by using statistical package 
for the social science-15 (SPSS-15). Analysis of data 
from 45 dogs randomly selected among patient dogs, 
as identified by clinical and laboratory methods, and 
healthy dogs, revealed a statistical significant differ-
ence between the groups. The data were presented as 
mean and standard error of the mean (SEM). The data 
distribution was evaluated by Kolmogorov-Smirnov 
test. Comparisons between groups were made by con-
ducting T test for continuous variables with a normal 
distribution, whilst variables with non-normal distri-
bution were analyzed with the Mann-Whitney U test. 
Receiver operating characteristic (ROC) curves and 
the area under these curves were used to assess the di-
agnostic potential of CRP, suPAR and neopterin lev-
els. ROC analyses were performed for both the dogs 
with SIRS and the healthy dogs. To assess the diag-
nostic potential of CRP, suPAR and neopterin levels 
in the diagnosis of SIRS, the area under curve (AUC) 
and some cut-off values were analyzed. The results 
were assessed at a 95% confidence interval and at a 
significance level of P < 0.05.
RESULTS
30 dogs with SIRS clinically inspected in detail 
and 15 healthy dogs were included in the study. Dogs 
< 6 months old were not included in the study. Dis-
eases causing SIRS include: gastrointestinal (n = 14), 
genital system (n = 4), malignant (n = 1), respiratory 
(n = 7), and dermatological (n = 4) diseases.
Table 1 presents changes in mean values of CRP, 
suPAR and neopterin levels of both dogs with SIRS 
and the healthy, and the significance in intergroup 
differences. In Figure 2-4, distribution of CRP, neop-
terin and suPAR among dogs with SIRS and healthy 
are presented. It was determined that the CRP, suPAR 
and neopterin concentrations of dogs with SIRS were 
significantly higher (P < 0.001, P < 0.01, P < 0.01, re-
spectively) than those of the dogs in the heathy group 
(Table 1).
ROC analysis was conducted on the CRP, suPAR 
and neopterin levels in the healthy animals and the 
dogs with SIRS. The ROC curves used to assess the 
diagnostic potential of CRP, suPAR and neopterin 
levels, are presented in Figure 1 and AUC are shown 
in Table 2. The ROC analysis was used to establish 
the cut-off, sensitivity and specificity values. Table 
2 shows the cut-off, sensitivity, specificity and AUC 
values of the CRP, suPAR and neopterin levels of 
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healthy dogs and dogs with SIRS. The cut-off values 
for the CRP, suPAR and neopterin levels were deter-
mined as 11.20 mg/L, 223.68 mg/L and 3.23 mmol/
mL, respectively. 
Based on ROC analysis, the area below the refer-
ence line is 0.99 for CPR, 0.69 for suPAR and 0.72 for 
neopterin, and that these biomarkers can offer signifi-
cant diagnostic information.
Figure 1. Receiver operating characteristic curve in the diagnosis of dogs with SIRS and healthy of serum levels CRP, suPAR and neopterin
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Figure 2. CRP levels in dogs with the systemic inflammatory response syndrome (n=30) and healthy (n=15)
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Figure 3. Neopterin levels in dogs with the systemic inflammatory response syndrome (n=30) and healty (n=15)
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Figure 4. suPAR levels in dogs with the systemic inflammatory response syndrome (n=30) and healthy (n=15)
Table 1. The CRP, suPAR, and neopterin levels of healthy dogs and dogs with SIRS (Mean±SEM)
Parameters Healthy group SIRS P value
CRP (mg/L) 4.30±0.95 66.59±6.57 < 0.001
suPAR (ng/L) 172.12 ±11.78 1001.79±287.60 0.007
Neopterin (nmol/mL) 2.63±0.15 21.08±6.36 0.007
CRP; C-reactive protein, suPAR; soluble urokinase-type plasminogen activator receptor
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Table 2. The cut-off, sensitivity, specificity and AUC values of the CRP, suPAR, and neopterin levels of healthy dogs and dogs with 
SIRS.
Parameters CRP (mg/L) suPAR (ng/L) Neopterin (nmol/mL)
AUC 0.99 0.69 0.72
Cut off 11.20 223.68 3.23
Sensitivity (%) 92.90 53.30 63.30
Specificity (%) 93.30 93.30 93.30
P value <0.001 0.039 0.018
SEM 0.011 0.079 0.077
AUC; area under the curve, SEM; standard error of mean, CRP; C-reactive protein, suPAR; soluble urokinase-type 
plasminogen activator receptor
DISCUSSION 
SIRS, which develops in various diseases in dogs, 
requires emergency treatment. Thus, urgent and cor-
rect diagnosis is critical. CRP is an acute phase protein 
released during tissue damage and inflammation. It is 
synthesized primarily in liver in response to stimula-
tion by cytokines and is defined as major acute phase 
protein identified in dogs. (Jitpean et al., 2014). Se-
rum CRP level in healthy dogs (Torrente et al., 2015) 
is < 35 mg/L (when analysis using LifeAssays mag-
netic permeability-based immunoassay), and it has 
been reported by various studies that it increases as 
a response to inflammatory stimulus (Viitanen et al., 
2014). Experimental studies have reported that CRP 
increases before the formation of clinical symptoms 
and reaches peak levels after 36 hours (Spapen et al., 
2006). It has also been reported that CRP increases in 
diseases such as leptospirosis, babesiosis, parvovirus 
infections, malignant tumors, pyometra, acute pancre-
atitis, immune hemolytic anemia, arthritis, glomeru-
lonephritis (Holm et al., 2004; Matijatko et al., 2007; 
Nakamura et al., 2008; Kocaturk et al., 2010; Tostes 
Oliveira et al., 2010). In a study on dogs with mono-
cytic ehrlichiosis, it has been found that CRP is an in-
dicator in determining the clinical phase of the diseas-
es, however, is not useful in determining the clinical 
result (Mylonakis et al., 2011). It was determined that 
high CRP levels in dogs with pyometra increased the 
rate of mortality and extended the treatment duration. 
CRP levels in dogs with no systemic inflammation 
ranged between 0.07-24.7 mg/L, and that CRP levels 
in dogs with systemic inflammation ranged between 
0.4-907.4 mg/L (Christensen et al., 2014). In this 
study, it was determined that average CRP levels of 
dogs with SIRS were significantly higher (P < 0.001) 
than those of healthy dogs. Besides, the CRP cut-off 
value was considered to be 11.20 mg/L for the healthy 
dogs and the dogs with SIRS with sensitivity 92.9%, 
and specificity 93.3%. In our study, it was observed 
that CRP has high sensitivity and specificity for the 
detection of systemic inflammatory response in dogs 
and can be evaluated as a good biomarker of inflam-
mation in dogs similar to other studies.
Biochemical markers are used to predict the mor-
bidity and mortality as well as the diagnosis of the 
pathological condition. In veterinary medicine, bio-
chemical parameters have been investigated for diag-
nostic and prognostic purposes in dogs with SIRS and 
sepsis (Kocaturk et al., 2010; Torrente et al., 2015; 
Ok et al., 2015). Inflammatory mediators showing im-
mune activation such as suPAR and neopterin are in-
vestigated in order to provide information on clinical 
diagnosis and prognosis of infectious diseases in hu-
man medicine (Murr et al., 2002; Eugen-Olsen 2011; 
Zeng et al., 2016). suPAR is a marker of fibrinolysis 
and inflammation that is released from immunolog-
ically active cells. suPAR reveals the patho-physi-
ological mechanisms that are active on cell surface 
(Wittenhagen et al., 2004; Kofoed et al., 2008; Kuleš 
et al., 2017). In a study comparing dogs with babesi-
osis and healthy ones, significant increases in suPAR 
levels were determined and it was stated that it would 
be useful in the evaluation of the stage of the disease. 
It was also reported that increased suPAR concentra-
tions may be a reflection of inflammatory response in 
dogs with babesiosis (Kuleš et al., 2017). In a study on 
patients with sepsis in intensive care, it was stated that 
there is an increase in suPAR level throughout acute 
inflammation (Kofoed et al., 2008). In another study, 
blood suPAR was shown to be significantly increased 
in patients with sepsis and stated that it was a valuable 
parameter to differentiate SIRS from sepsis. They 
also reported that the use of suPAR and procalcitonin 
(PCT) combination increases the diagnostic effica-
cy for sepsis in human medicine (Zeng et al., 2016). 
In other studies, it was found that suPAR increased 
significantly in people with SIRS and sepsis, but it 
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was concluded that the diagnostic value of suPAR in 
sepsis was insufficient according to classical markers 
such as PCT and CRP. The reason for this is that the 
strong induction of PCT and CRP with lipopolysac-
charides may explain its benefits in the diagnosis of 
bacterial infection, whereas suPAR is induced at a 
lower level with bacterial proteins such as lipopoly-
saccharide. Considering all these results, suPAR has 
limited diagnostic value in sepsis compared to clas-
sical markers such as PCT and CRP (Kofoed et al., 
2007; Koch et al., 2011; Hoenigl et al., 2013; Bilgili 
and Cinel 2013). The study revealed that the average 
suPAR levels of dogs with SIRS were significantly 
higher (P < 0.01) than those of healthy dogs. The cut-
off value of suPAR was considered as 223.68 ng/L for 
healthy dogs and dogs with SIRS, its sensitivity was 
determined to be low (53.3%), and its specificity as 
high (93.3%). In our study, it was found that suPAR 
had low sensitivity compared to CRP, which is a good 
marker for the detection of inflammation in dogs. The 
results of our study show that suPAR is insufficient 
for the diagnosis of systemic inflammatory response 
in dogs similar to the studies in human medicine.
Neopterin is a critical indicator for cellular im-
mune system activation released by monocytes and 
macrophages (Hoffmann et al., 2003). It was deter-
mined that in intensive care units neopterin levels 
of patients with sepsis, septic shock, SIRS, or with 
multiple organ failure increased (Berdowska and 
Zwirska‐Korczala 2001; Alberti et al., 2003; Baydar 
et al., 2009). It was reported that the neopterin level 
increased in viral, bacterial, and parasitic infections, 
apart from sepsis (Berdowska and Zwirska‐Korcza-
la 2001; Murr et al., 2002). It was stated that the ne-
opterin levels increased in neonatal calves with sep-
tisemic colibacillosis, in relation to IFN-γ as a defense 
mechanism (Ercan et al., 2016). In a study conducted 
on 208 intensive care patients in human medicine, 
the cut-off value of the recommended neopterin for 
the diagnosis of infection was 18 pg/L (Brunkhorst 
et al., 1999). In the study, it was found that the se-
rum neopterin levels of dogs with SIRS was higher in 
comparison to the healthy dogs and that this increase 
is statistically significant (P < 0.01). The cut-off val-
ue of neopterin was considered as 3.23 nmol/mL for 
SIRS, with sensitivity 63.3%, and specificity 93.3%. 
In this study, the sensitivity of neopterin was found to 
be lower than CRP, although higher than suPAR. In 
human medicine (Brunkhorst et al., 1999), neopterin 
has been reported to be more sensitive than classical 
markers of inflammation (such as procalcitonin). On 
the contrary, in this study, it was observed that sys-
temic inflammation in dogs is less sensitive than CRP, 
one of the classical biomarkers. 
CONCLUSIONS
It was supported by the comparative ROC analysis 
that CRP has more diagnostic significance than neop-
terin and suPAR. In the ROC analysis, it was deter-
mined that CRP had the highest sensitivity, followed 
by neopterin and suPAR, respectively, and that CPR, 
suPAR and neopterin had the same values in terms 
of specificity. As a result, we determined that CRP 
showed the best performance for detection of system-
ic inflammatory response in dogs, and neopterin and 
suPAR could be used as an alternative to CRP. It is 
also concluded that further studies are necessary in 
order to determine diagnosis and prognosis of diseas-
es.
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